LSTA (Lisata Therapeutics) Cyclically Adjusted FCF per Share: $-18.45 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSTA Lisata Therapeutics Inc LSTA
22 GF Score
Price $1.79
! 3 Warning Signs
View Full Analysis

What is Lisata Therapeutics Cyclically Adjusted FCF per Share?

Lisata Therapeutics LSTA +15.86% 22 Cyclically Adjusted FCF per Share is $-18.45 as of Jun. 2026. GuruFocus rates LSTA with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Lisata Therapeutics's adjusted free cash flow per share for the three months ended in Jun. 2026 was $-0.291. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-18.45 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 37.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 29.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 32.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Lisata Therapeutics was 37.90% per year. The lowest was 8.90% per year. And the median was 25.10% per year.

As of today (2026-08-24), Lisata Therapeutics's current stock price is $1.79. Lisata Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $-18.45. Lisata Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Lisata Therapeutics  (NAS:LSTA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Lisata Therapeutics Cyclically Adjusted FCF per Share Related Terms


Lisata Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Lisata Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lisata Therapeutics Cyclically Adjusted FCF per Share Chart

Lisata Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -105.68 -95.48 -69.92 -41.04 -23.31

Lisata Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.00 -26.73 -23.31 -20.50 -18.45

LSTA vs CYCN, OSRH, ICU: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Lisata Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


LSTA
22GF Score
Lisata Therapeutics Inc LSTA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lisata Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lisata Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.291/333.9520*333.9520
=-0.291

Current CPI (Jun. 2026) = 333.9520.

Lisata Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -13.547 241.428 -18.739
201612 -6.238 241.432 -8.628
201703 -18.172 243.801 -24.892
201706 -0.866 244.955 -1.181
201709 -10.480 246.819 -14.180
201712 -6.319 246.524 -8.560
201803 -9.903 249.554 -13.252
201806 -9.213 251.989 -12.210
201809 -7.512 252.439 -9.938
201812 -4.630 251.233 -6.154
201903 -8.213 254.202 -10.790
201906 -6.810 256.143 -8.879
201909 -6.422 256.759 -8.353
201912 -6.046 256.974 -7.857
202003 -5.993 258.115 -7.754
202006 5.121 257.797 6.634
202009 -2.837 260.280 -3.640
202012 -4.307 260.474 -5.522
202103 -2.840 264.877 -3.581
202106 -1.166 271.696 -1.433
202109 -1.268 274.310 -1.544
202112 -1.154 278.802 -1.382
202203 -1.398 287.504 -1.624
202206 -1.255 296.311 -1.414
202209 -0.842 296.808 -0.947
202212 -0.819 296.797 -0.922
202303 -1.026 301.836 -1.135
202306 -0.522 305.109 -0.571
202309 -0.440 307.789 -0.477
202312 -0.500 306.746 -0.544
202403 -0.847 312.332 -0.906
202406 -0.636 314.175 -0.676
202409 -0.303 315.301 -0.321
202412 -0.539 315.605 -0.570
202503 -0.631 319.799 -0.659
202506 -0.460 322.561 -0.476
202509 -0.382 324.800 -0.393
202512 -0.369 324.054 -0.380
202603 -0.342 330.213 -0.346
202606 -0.291 333.952 -0.291

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-18.45 mean?
Lisata Therapeutics (LSTA) has a Cyclically Adjusted FCF per Share of $-18.45 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Lisata Therapeutics and its competitors.
Is Lisata Therapeutics' Cyclically Adjusted FCF per Share too high?
Lisata Therapeutics' current Cyclically Adjusted FCF per Share is $-18.45. Overall, Lisata Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Lisata Therapeutics' Cyclically Adjusted FCF per Share compare to CYCN and OSRH?
Lisata Therapeutics' Cyclically Adjusted FCF per Share of $-18.45 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Lisata Therapeutics and its competitors. Lisata Therapeutics's current Cyclically Adjusted FCF per Share is $-18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lisata Therapeutics stock overvalued right now?
Lisata Therapeutics (LSTA) has a current Cyclically Adjusted FCF per Share of $-18.45. The current Cyclically Adjusted FCF per Share is $-18.45. Lisata Therapeutics' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Lisata Therapeutics (LSTA), the current Cyclically Adjusted FCF per Share is $-18.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lisata Therapeutics Business Description

Other Exchanges 0HS8:UK8NE:Germany
Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
22GF Score

Get the complete analysis for LSTA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.79
Price